Skip to main content

Javier Inserte Igual

-

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Cardiology
General Hospital

Javier Inserte Igual

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca
Cardiology
General Hospital

-

-

Projects

Las proteasas carpaínas como nuevas dianas terapéuticas en el remodelado ventricular e insuficiencia cardíaca postinfarto

IP: Javier Inserte Igual
Collaborators: Antonio Rodríguez Sinovas, Ignasi Barba Vert
Funding agency: -Sociedad Española de Cardiologia
Funding: 18000
Reference: SEC-2012-02
Duration: 18/10/2012 - 17/10/2013

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Red Cardiovascular, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Targeting inflammation to improve heart repair and regeneration

IP: -
Collaborators: David Aluja Gonzalez, Ignasi Barba Vert, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual
Funding agency: Fundació La Marató de TV3
Funding: 150000
Reference: 121930
Duration: 30/01/2013 - 31/12/2016

Caracterización de los mecanismos de regulación de la proteasa calpaína durante la isquemia/reperfusión miocárdica y su contribución a la muerte celular

IP: Javier Inserte Igual
Collaborators: Angeles Rojas Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 43802
Reference: PI080238
Duration: 01/01/2009 - 31/12/2011

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

María  Puigcerver  Mas

María Puigcerver Mas

Physiology and Pathophysiology of the Digestive Tract
Read more
Andrea Onieva Salgado

Andrea Onieva Salgado

Predoctoral researcher
Gene Therapy at Nervous System
Read more
Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Sara García González

Sara García González

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.